Qi Zhu
Baoshan Branch
Shanghai, 200444, China
Shanghai, 200444, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Targeting H3K27me3 methyltransferase EZH2 restrains ANGPT2 signaling in choroidal neovascularization.
Journal: Experimental eye research
Published: January 17, 2026
Erratum: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance.
Journal: American journal of cancer research
Published: March 25, 2025
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells.
Journal: Acta pharmaceutica Sinica. B
Published: March 28, 2024
Maternal cognitive and affective empathy related to preschoolers' emotional-behavioral problems: moderation of maternal depression.
Journal: Pediatric research
Published: December 14, 2023
Current state of the clinical nurses' job satisfaction and influence factors.
Journal: Minerva medica
Published: December 01, 2023
Construction and Validation of a risk model Based on Cuprotosis-related LncRNAsin Colon Adenocarcinoma.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: December 18, 2022
Induction with MEDA regimen and consolidation with Auto-HSCT for stage IV NKTCL patients: A prospective multicenter study.
Journal: International journal of cancer
Published: November 10, 2021
Early language and communication development in Chinese children: Adaption and validation of a parent report instrument.
Journal: International journal of speech-language pathology
Published: October 16, 2020
Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China.
Journal: Cancer communications (London, England)
Published: September 07, 2020
YL064 activates proteasomal-dependent degradation of c-Myc and synergistically enhances the anti-tumor activity of ABT-199 in diffuse large B cell lymphoma.
Journal: Signal transduction and targeted therapy
Published: February 14, 2020
Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity.
Journal: Cell death & disease
Published: September 21, 2018
YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells.
Journal: Cell death discovery
Published: August 14, 2018
Last Updated: 09/26/2026